Metabolic Flexibility Predicts Response to Saroglitazar in Liver Transplant Recipients With Metabolic Dysfunction-associated Steatotic Liver Disease
Transplantation
.
2025 Apr 1;109(4):e222-e223.
doi: 10.1097/TP.0000000000005324.
Epub 2025 Feb 11.
Authors
Kavin Parmar
1
,
Anh Tuan Bui
2
,
Taufik Momin
3
,
Idris Yakubu
4
,
Vaishali Patel
1
,
Mohammad Shadab Siddiqui
1
Affiliations
1
Division of Gastroenterology and Hepatology, Virginia Commonwealth University, Richmond, VA.
2
Department of Statistical Sciences and Operations Research, Virginia Commonwealth University, Richmond, VA.
3
Zydus Therapeutics, Pennington, NJ.
4
Division of Transplant Surgery, Virginia Commonwealth University, Richmond, VA.
PMID:
39930572
DOI:
10.1097/TP.0000000000005324
No abstract available
Grants and funding
Zydus Therapeutics